Examkin

Question

Difficulty: HardPreventive Care and Immunizations

A 5-year-old girl presents to the clinic with her adoptive parents for an initial health assessment. The family recently immigrated, and the parents state that the child has no previous medical or vaccination records. The patient's past medical history is notable for severe persistent asthma. Three weeks prior to her arrival, she suffered a severe asthma exacerbation that required a pediatric intensive care unit admission. She was discharged on a regimen of oral prednisone 2 mg/kg daily, which she has continued taking for the past 21 days. Her other medications include high-dose inhaled fluticasone and as-needed albuterol. Vital signs are within normal limits. Physical examination reveals cushingoid features but is otherwise unremarkable, with clear breath sounds bilaterally. The physician is planning her catch-up immunization schedule. Which of the following is the most appropriate immunization management for this patient at today's visit?

  1. Administer DTaP, inactivated poliovirus, and hepatitis B vaccines; defer all live-attenuated vaccinesAnswer
  2. B
    Administer DTaP, inactivated poliovirus, hepatitis B, MMR, and varicella vaccines
  3. C
    Administer DTaP, inactivated poliovirus, hepatitis B, and live-attenuated intranasal influenza vaccines
  4. D
    Administer Tdap, inactivated poliovirus, hepatitis B, MMR, and varicella vaccines
  5. E
    Defer all immunizations until the oral prednisone has been discontinued for at least 4 weeks

Answer

Administer DTaP, inactivated poliovirus, and hepatitis B vaccines; defer all live-attenuated vaccines
The correct management is to administer age-appropriate inactivated vaccines while deferring all live-attenuated vaccines. This 5-year-old patient has an undocumented immunization status and must initiate the catch-up schedule. She is currently taking high-dose oral prednisone (2 mg/kg/day for 21 days). Systemic corticosteroid therapy is considered severely immunosuppressive when administered at doses of ≥2 mg/kg/day or ≥20 mg/day for ≥14 consecutive days. In such patients, live-attenuated vaccines (e.g., MMR, varicella, live-attenuated intranasal influenza) are strictly contraindicated due to the risk of uncontrolled vaccine-strain viral replication and disseminated infection. These live vaccines must be deferred until at least 4 weeks after the high-dose corticosteroids have been discontinued. Conversely, inactivated vaccines (such as DTaP, IPV, and hepatitis B) carry no risk of vaccine-strain infection and are safe to administer to immunocompromised hosts. Furthermore, because the patient is 5 years old, DTaP is the correct pertussis-containing formulation, as Tdap is reserved for children 7 years of age and older.

Step-by-Step Solution

1
Determine the patient's baseline immunization needs.
As an international adoptee with no immunization records, the patient is considered unimmunized and requires a full catch-up schedule.
Undocumented vaccines cannot be assumed to have been administered.
2
Assess the patient's current immune status based on her medication history.
The patient is taking oral prednisone at 2 mg/kg/day for 21 days, which constitutes severe immunosuppression.
Corticosteroid doses of ≥2 mg/kg/day or ≥20 mg/day for ≥14 days cause clinically significant immunosuppression.
3
Apply vaccine guidelines for severely immunocompromised patients.
Live-attenuated vaccines (e.g., MMR, varicella) are contraindicated and must be deferred. Inactivated vaccines (e.g., DTaP, IPV, hepatitis B) are safe to administer.
Live vaccines pose a risk of vaccine-strain viral replication and disseminated infection in immunocompromised hosts, whereas inactivated vaccines pose no such risk.
4
Select the appropriate vaccine formulations based on the patient's age.
The patient is 5 years old, so she should receive DTaP rather than Tdap.
DTaP is indicated for children under 7 years of age, while Tdap is indicated for individuals 7 years and older.

Key Concept

In patients receiving high-dose systemic corticosteroids (≥2 mg/kg/day or ≥20 mg/day of prednisone for ≥14 days), live-attenuated vaccines are strictly contraindicated until at least 4 weeks after discontinuation, whereas inactivated vaccines can be safely administered on schedule.
Rate this question

Topics

Preventive Care and Immunizations

More questions from this topic